Indication
Cardiac Fibrosis
8 clinical trials
8 products
2 drugs
Clinical trial
Characterization of Heart Failure With Preserved Ejection FractionStatus: Recruiting, Estimated PCD: 2028-12-01
Product
biomarkerClinical trial
Phase IA Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's AtaxiaStatus: Recruiting, Estimated PCD: 2028-12-31
Product
AAVrh.10hFXNProduct
PrednisoneClinical trial
The Role of Losartan in the Prevention of Early Structural Changes Associated With Radiation-Induced Heart FailureStatus: Recruiting, Estimated PCD: 2024-10-01
Drug
LosartanClinical trial
Use of Metformin in Prevention and Treatment of Cardiac Fibrosis in PAI-1 Deficient PopulationStatus: Active (not recruiting), Estimated PCD: 2027-10-01
Product
Metformin Extended ReleaseClinical trial
Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286Status: Recruiting, Estimated PCD: 2024-12-31
Product
68Ga-FAP-2286Clinical trial
High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar AssessmentStatus: Not yet recruiting, Estimated PCD: 2025-12-01
Product
EluciremClinical trial
The Effect of Henagliflozin and Metformin on Myocardial Tissue-level Characteristics in Patients With Type 2 Diabetes and Obesity: A Prospective, Randomized, Open-label, Active Drug Controlled Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Product
HenagliflozinDrug
MetforminClinical trial
Study of Novel PET Tracer Gallium [68Ga]/ Fluorine [18F] -FAPI-04 in the Diagnosis of Cardiovascular DiseasesStatus: Recruiting, Estimated PCD: 2025-12-31
Product
68Ga/18F-FAPI-04